Hematopoietic stem cell transplantation ocular complications: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Affiliation auteursAffiliation ok
TitreHematopoietic stem cell transplantation ocular complications: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Type de publicationJournal Article
Year of Publication2020
AuteursBorel C, Ahmad I, Ceballos P, Desbrosses Y, Hamzy F, Ravinet A, Souchet L, Turlure P, Villate A, Yakoub-Agha I, Guillaume T
JournalBULLETIN DU CANCER
Volume107
PaginationS116-S121
Date PublishedDEC
Type of ArticleArticle
ISSN0007-4551
Mots-clésAllogeneic transplantation, Eye, graft-versus-host disease, Hematopoietic stem cell, Ocular, Ophtalmologic
Résumé

Introduction > Allogeneic stem cell transplantation is currently the only curative therapy for hematological disorders. This treatment can lead to complications, of which ophtolmological involvement. Methods > We reviewed the literature and established accessible and convenient recommendations for hematologists and ophthalmologists. Results > Ophtalmological follow-up should be done in every patient having hod an allogeneic transplantation, by the hematologist questioning and by the ophthalmologist physical exam. Complications due to graft-versus-host disease (GVHD) or not due to GVHD ore cited, as well as therapeutic options. Discussion > Screening and treatment of ophthalmologic complications in allogeneic stem cells transplantation recipients requires a close collaboration between hematologists and ophthalmologists. The management of these patients by caregivers trained in these questions is encouraged.

DOI10.1016/j.bulcan.2020.04.014